• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=18534018).
  

PubMed=7705946; DOI=10.1002/ijc.2910610208
Combaret V., Turc-Carel C., Thiesse P., Rebillard A.-C., Frappaz D., Haus O., Philip T., Favrot M.-C.
Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses.
Int. J. Cancer 61:185-191(1995)

DOI=10.1007/0-306-46872-7_2
Thiele C.J.
Neuroblastoma.
(In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999)

PubMed=18534018; DOI=10.1186/1476-4598-7-50; PMCID=PMC2442611
Combaret V., Boyault S., Iacono I., Brejon S., Rousseau R., Puisieux A.
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity.
Mol. Cancer 7:50.1-50.12(2008)

PubMed=20160348; DOI=10.1172/JCI41013; PMCID=PMC2827960
Bouzas-Rodriguez J., Cabrera J.R., Delloye-Bourgeois C., Ichim G., Delcros J.-G., Raquin M.-A., Rousseau R., Combaret V., Benard J., Tauszig-Delamasure S., Mehlen P.
Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.
J. Clin. Invest. 120:850-858(2010)